Literature DB >> 11224078

Dose-related caffeine discrimination in normal volunteers: individual differences in subjective effects and self-reported cues.

S.M. Evans1, R.R. Griffiths.   

Abstract

A within subject design was used to study a caffeine versus placebo drug discrimination in five volunteers who were not explicitly instructed that the drug conditions involved caffeine and placebo. The caffeine (200 or 300mg) versus placebo discrimination was acquired by all subjects and remained stable (78-90% accuracy) throughout the study which spanned 5 to 8.7 months across the subjects. A full caffeine dose-response function (50 to 400 or 600mg) was determined repeatedly under test conditions in each subject; caffeine produced orderly dose-related increases in caffeine identification in all subjects. The present study evaluated individual subject data to examine the correspondence between the subjective effects of caffeine versus placebo and the cues subjects reported as being important to making the discrimination. Although the subjective effects and self-reported cues differed across subjects, there was a correspondence within subjects. Prominent self-reported cues for caffeine included jittery/nervous/anxious (four subjects) and alert/active (one subject); self-reported cues for placebo included tired and/or headache (three subjects) and absence of drug effect (two subjects). The reporting of tired and headache as cues for the placebo condition suggests that caffeine withdrawal may produce stimulus effects relevant to the caffeine versus placebo discrimination.

Entities:  

Year:  1991        PMID: 11224078

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  7 in total

1.  ADORA2A Gene variation, caffeine, and emotional processing: a multi-level interaction on startle reflex.

Authors:  Katharina Domschke; Agnieszka Gajewska; Bernward Winter; Martin J Herrmann; Bodo Warrings; Andreas Mühlberger; Katherina Wosnitza; Evelyn Glotzbach; Annette Conzelmann; Andrea Dlugos; Manfred Fobker; Christian Jacob; Volker Arolt; Andreas Reif; Paul Pauli; Peter Zwanzger; Jürgen Deckert
Journal:  Neuropsychopharmacology       Date:  2011-10-19       Impact factor: 7.853

2.  Drug tasting may confound human drug discrimination studies.

Authors:  M E Abreu; R R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

3.  Discriminative stimulus effects of diazepam and buspirone in normal volunteers.

Authors:  C R Rush; T S Critchfield; J R Troisi; R R Griffiths
Journal:  J Exp Anal Behav       Date:  1995-05       Impact factor: 2.468

Review 4.  Drug discrimination by humans compared to nonhumans: current status and future directions.

Authors:  J B Kamien; W K Bickel; J R Hughes; S T Higgins; B J Smith
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety.

Authors:  Emma Childs; Christa Hohoff; Jürgen Deckert; Ke Xu; Judith Badner; Harriet de Wit
Journal:  Neuropsychopharmacology       Date:  2008-02-27       Impact factor: 7.853

6.  Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM.

Authors:  N Amin; E Byrne; J Johnson; G Chenevix-Trench; S Walter; I M Nolte; J M Vink; R Rawal; M Mangino; A Teumer; J C Keers; G Verwoert; S Baumeister; R Biffar; A Petersmann; N Dahmen; A Doering; A Isaacs; L Broer; N R Wray; G W Montgomery; D Levy; B M Psaty; V Gudnason; A Chakravarti; P Sulem; D F Gudbjartsson; L A Kiemeney; U Thorsteinsdottir; K Stefansson; F J A van Rooij; Y S Aulchenko; J J Hottenga; F R Rivadeneira; A Hofman; A G Uitterlinden; C J Hammond; S-Y Shin; A Ikram; J C M Witteman; A C J W Janssens; H Snieder; H Tiemeier; B H R Wolfenbuttel; B A Oostra; A C Heath; E Wichmann; T D Spector; H J Grabe; D I Boomsma; N G Martin; C M van Duijn
Journal:  Mol Psychiatry       Date:  2011-08-30       Impact factor: 15.992

7.  Subjective, behavioral, and physiological effects of acute caffeine in light, nondependent caffeine users.

Authors:  Emma Childs; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2006-03-16       Impact factor: 4.415

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.